Drugs Made In America Acquisition (DMAAR) Stock: Why It's Down Today
Updated Oct 20, 2026, 12:04 PM ET · intraday price
- Trading at $0.12 as of 12:04 PM ET, -0.59% vs the prior close of $0.12.
- Volume 49.36K shares, 1.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DMAAR dips 0.6% to $0.12. Trading at $0.12 (intraday, 12:04 PM ET), -0.59% vs the prior close of $0.12. Day range $0.09–$0.12, opened at $0.11.
DMAAR daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — DMAAR dips 0.6% to $0.12
- Trading at $0.12 (intraday, 12:04 PM ET), -0.59% vs the prior close of $0.12. Day range $0.09–$0.12, opened at $0.11.
- Volume was 49.36K shares, 1.7x its 50-day average of 29.87K.
- 52-week range $0.09–$0.12; the current price sits at 97% of that range, 0.7% below the 52-week high.
DMAAR bull case vs bear case (from the data)
- Latest fiscal-year net income: profit of $5.94M.
- Share count down 27.6% in a year (buybacks).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
DMAAR latest news & SEC filings
Every SEC filing by or about DMAAR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $1.73M (prior year $2.29M) (-24.5% vs Jun 30, 2025)
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Jun 26, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade DMAAR
- How much it moves: over the last 20 sessions the average daily move was 0.59% (largest 0.6%). That is a relatively calm stock.
- Liquidity: about 39.61K shares (≈$4.71K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.12 vs a range of $0.09–$0.12 (97% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 14, 2026; 8-K Jul 20, 2026.
- Share count: 24.28M shares outstanding (Aug 14, 2026), -27.6% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Blank Checks.
DMAAR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 0.11 | 0.12 | 0.09 | 0.12 | 49.36K |
| Oct 15, 2026 | 0.11 | 0.12 | 0.12 | 0.12 | 29.87K |
About Drugs Made In America Acquisition
Drugs Made In America Acquisition (DMAAR) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in NEW YORK, NY. Fiscal year ends December 31. SEC CIK 2028614.
DMAAR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
DMAAR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $5.94M | — | $-539.19K |
Latest balance sheet: total assets $146.90M, total liabilities $9.14M, cash $20.28K (as of Jun 30, 2026).
DMAAR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Bold Eagle Acquisition (BEAG)Southport Acquisition Corp. II (PORT-UN)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Archimedes Tech SPAC Partners II (ATII)Frazier Life Sciences Acquisition Corp. II (FLSC)Bluerock Acquisition Corp. II (BRRKU)Innventure (INV)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on DMAAR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 12:04 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.